Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers
- 23 September 2022
- journal article
- review article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 39 (1) , 1-31
Abstract
Evodiamine is a major alkaloid component found in the fruit of Evodia rutaecarpa. It shows the anti-proliferative potential against a wide range of cancers by suppressing cell growth, invasion, and metastasis and inducing apoptosis both in vitro and in vivo. Evodiamine shows its anticancer potential by modulating aberrant signaling pathways. Additionally, the review focuses on several therapeutic implications of evodiamine, such as epigenetic modification, cancer stem cells, and epithelial to mesenchymal transition. Moreover, combinatory drug therapeutics along with evodiamine enhances the anticancer efficacy of chemotherapeutic drugs in various cancers by overcoming the chemo resistance and radio resistance shown by cancer cells. It has been widely used in preclinical trials in animal models, exhibiting very negligible side effects against normal cells and effective against cancer cells. The pharmacokinetic and pharmacodynamics-based collaborations of evodiamine are also included. Due to its poor bioavailability, synthetic analogs of evodiamine and its nano capsule have been formulated to enhance its bioavailability and reduce toxicity. In addition, this review summarizes the ongoing research on the mechanisms behind the antitumor potential of evodiamine, which proposes an exciting future for such interests in cancer biology. Graphical abstractKeywords
Funding Information
- Department of Science and technology, Science and Engineering Research Board (DST, SERB), New Delhi, India (ECR/2016/000792)
- Department of Science and Technology, Odisha, India (1201)
This publication has 174 references indexed in Scilit:
- Anti-Proliferative Effects of Evodiamine on Human Breast Cancer CellsPLOS ONE, 2013
- Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric TumorsPLOS ONE, 2013
- Negative Feedback and Adaptive Resistance to the Targeted Therapy of CancerCancer Discovery, 2012
- Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral BioavailabilityAAPS PharmSciTech, 2012
- Targeting the EGFR signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung CancerJournal of Thoracic Oncology, 2011
- Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive componentsChinese Medicine, 2011
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Epigenetics in cancerCarcinogenesis, 2009